Rhinigenta, 1,5 mg/ml oplossing voor intranasale toediening voor honden en katten
Rhinigenta, 1,5 mg/ml oplossing voor intranasale toediening voor honden en katten
Authorised
- Gentamicin
Product identification
Medicine name:
Rhinigenta, 1,5 mg/ml oplossing voor intranasale toediening voor honden en katten
Active substance:
- Gentamicin
Target species:
-
Dog
-
Cat
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Gentamicin1.50milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Nasal spray, solution
Withdrawal period by route of administration:
-
Nasal use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS01AA11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Ast Farma B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 5135
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/02/2022
How useful was this page?: